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Abstract: The cyclic lipopeptide Daptomycin, used as a treatment 
for infections where antimicrobial resistance is observed, is shown to 
self-assemble into spherical micelles above a critical aggregation 
concentration. Micelles are observed either in the absence or 
presence of CaCl2, in contrast to claims in the literature that CaCl2 is 
required for micellization. 
Daptomycin is a cyclic lipopeptide drug produced by the gram-
positive bacterium Streptomyces roseosporous.[1] It is also 
known under the tradename Cubicin and is used as an antibiotic 
to treat serious infections caused by Gram positive bacteria.[2] It 
is effective against infections where antimicrobial resistance 
(AMR) is a problem, including methicillin-resistant 
Staphylococcus aureus (MRSA)[1b] and vancomycin-resistant 
Enterococci.[2-3] As shown in figure 1, Daptomycin is composed 
of 13 amino acids, 10 making up the cyclic structure and the 
other three forming a chain. The cyclic section of the molecule is 
linked through an ester bond to the tail through the terminal 
kynurenine residue, an unusual non-canonical amino acid 
product of tryptophan metabolism, and the threonine hydroxyl 
group.[2] Although Daptomycin is negatively charged, it is able to 
interact with the negatively charged bacterial cell membrane, in 
the presence of cations. In particular it is indicated that its in vitro 
antibiotic activity requires the presence of calcium ions.[4] 
 
The consensus mechanism of action of Daptomycin involves 
disruption of the bacterial cell membrane by insertion of the 
lipophilic N-terminal decanoyl chain into the membrane.[3, 5] This 
then allows the flow of potassium ions out of the cell, which 
causes depolarisation, and is proposed to be the cause of cell 
death.[6] There is also the possibility of an additional factor 
 
 
 
 
 
 
 
 
 
Scheme 1. Molecular structure of Daptomycin 
 
contributing towards its activity that results from oligomerisation 
in the presence of calcium ions, causing disruption of cell 
membrane when the oligomer dissociates at the bacterial 
membrane.[7] The antimicrobial activity is calcium-dependent, 
although the reasons are poorly understood. It has been 
reported that a 1:1 ratio of Ca2+ to Daptomycin leads to 
aggregation, although this does not lead to a change in 
Daptomycin conformation.[7-8] In the absence of calcium ions, 
three different structures have been proposed (based on NMR 
experiments) for Daptomycin, none of which are highly 
amphiphilic.[7] At one molar equivalent of added Ca2+ ions, it is 
proposed (based on ultracentrifugation and NMR experiments) 
that 14-16 daptomycin monomers oligomerise, likely into a 
micelle.[7, 9] When the oligomer is in close proximity to the 
bacterial membrane, it dissociates and the insertion process 
described before occurs.  
 
Despite this prior work, there is no direct prior evidence for the 
nature of the self-assembled structures of Daptomycin. In the 
present paper we use a powerful combination of in situ 
techniques to examine micellization of Daptomycin. Cryogenic-
transmission electron microscopy (cryo-TEM) provides direct 
images of small spherical micelles, the structure of which is also 
elucidated using small-angle X-ray scattering (SAXS). The 
critical micelle concentration is determined using an auto-
fluorescence assay. The kynurenine residue in Daptomycin, 
containing an aniline component, is responsible for a strong 
fluorescence emission peak at 460 nm.[5a] Another emission 
peak at 355 nm is due to Trp-1.[5a] These peaks enable 
fluorescence assays based on intrinsic fluorescence, without the 
use of probes sensitive to the local hydrophobic environment 
such as pyrene widely used in critical micelle concentration 
assays. We also investigate the secondary structure of 
Daptomycin using a combination of spectroscopic methods 
including circular dichroism (CD) and FTIR. 
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Figure 1. Critical aggregation concentration assay for Daptomycin in 100 mM 
KCl solution with no CaCl2 or with Daptomycin:CaCl2 = 4 : 1 or 1:1. 
 
Results from fluorescence assays based on the self-
fluorescence peak of Daptomycin at 466 nm are shown in Fig.1 
(the original spectra are shown in Fig. S1). The data shown in 
Fig.1a performed for Daptomycin in the presence of 100 mM KCl 
reveal a discontinuity at a concentration of (0.020 ± 0.003 wt%) 
(0.02 wt%  0.12 mM), remarkably independent of CaCl2 content. 
These molar ratios of added CaCl2 were selected based on prior 
work[3, 7, 9]). These values indicate that Daptomycin undergoes a 
CaCl2-independent critical aggregation concentration (cac). The 
value obtained from our measurements is the same as the cac= 
0.12 mM obtained previously in pH 4 aqueous solution (without 
salts) on the basis of auto-fluorescence with similar values 
obtained from dynamic light scattering.[5a] It has also been 
reported that Daptomycin aggregates above 1 mM in aqueous 
solution, although the (salt) conditions were not specified.[4b]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Circular dichroism spectra for 0.1 wt% Daptomycin solutions in (a) 
100 mM KCl solution, (b) 100 mM KCl solution with Daptomycin CaCl2 = 4 : 1. 
 
 
The secondary structure of Daptomycin in aqueous (100 mM 
KCl) solution was investigated in the absence and presence of 
CaCl2 using circular dichroism (CD) and FTIR spectroscopies. 
Fig.2 and Fig.S2 show CD spectra which are very similar in 
shape with or without CaCl2 (at 4:1 molar ratio Daptomycin: 
CaCl2 or at a 1:1 molar ratio) In addition, there is very little 
temperature dependence in the range examined, 20 – 60 oC. 
The spectra in the far UV region are consistent with a reported 
spectrum for 6M Daptomycin in 5 mM CaCl2.[3] The main 
features are the maximum at 231 nm, consistent with previously 
reportedly spectra,[3] and a peak at 258 nm, consistent with the 
measured absorption spectrum of Daptomycin and 
kynurenine.[4b, 5a] In the near UV region (Fig.2b,c), each 
spectrum shows a minimum near 300 nm and a maximum at 
360-370 nm. The latter feature is ascribed to absorbance from 
the kynurenine unit.[4b, 5a] A key feature of the CD spectra in Fig.2 
is the similarity in shape for solutions with or without CaCl2. 
 
As shown in Fig.3, the FTIR spectra measured for Daptomycin 
solutions with or without CaCl2 are very similar in the 1250 – 
2000 cm-1 range. Strong peaks are observed at 1454 cm-1 and 
1648 cm-1 with a weak additional peak at 1580 cm-1 along with a 
shoulder at 1720 cm-1. The 1454 cm-1 peak is assigned to HDO 
stretching deformations, the formation of HDO resulting from 
H/D exchange between protons and D2O,[10] although there is 
also a Trp side group deformation possible at this 
wavenumber.[11] The peak in the amide I´ band at 1648 cm-1 
indicates an unordered peptide conformation.[11b, 12] The 1720 
cm-1 peak is assigned to carbonyl stretch.[13] 
 
 
 
 
 
 
200 250 300 350 400 450
-6
-5
-4
-3
-2
-1
0
1
2
 
 
1
0
-4
[
] 
/d
e
g
 c
m
2
 d
m
o
l-1
wavelength / nm
 20°C
 30°C
 40°C
 50°C
 60°C
 20°C cooled
(a)
200 250 300 350 400 450
-10
-8
-6
-4
-2
0
2
 
 
1
0
-4
[
] 
/d
e
g
 c
m
2
 d
m
o
l-1
wavelength / nm
 20°C
 30°C
 40°C
 50°C
 60°C
 20°C cooled
(b)
-3.0 -2.5 -2.0 -1.5 -1.0
0
200
400
600
800
1000
 
 
In
te
n
s
it
y
 /
 a
. 
u
.
log [concentration / wt%]
 Daptomycin
 Daptomycin 4:1 CaCl
2
 Daptomycin 1:1 CaCl
2
COMMUNICATION          
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. FTIR spectra from 1 wt% Daptomycin solutions in 100 mM KCl D2O 
solutions with and without CaCl2, as indicated. 
 
There is a significant difference in the intensity of the peak at 
3400 cm-1, which is substantially enhanced in the CaCl2 
solutions. This peak is assigned to the –OH stretch vibration[13] 
and its reduced intensity for the salt solution reflects the salt-
induced disruption of hydrogen bonds involving –OH groups in 
the acidic residues within Daptomycin. The FTIR data supports 
the results from CD, showing an unordered peptide 
conformation which is not changed in the presence of CaCl2. 
 
Figure 4. Cryo-TEM images from 0.5 wt% Daptomycin solutions with (a, b) 
100 mM KCl (c, d) 100 mM KCl +  0.77 mM CaCl2, (e,f) 100 mM KCl + 3.09 
mM CaCl2.  
The self-assembly of Daptomycin in the presence and absence 
of CaCl2 was examined using cryogenic-TEM. Representative 
images are shown in Fig.4. These clearly reveal the presence of 
spherical micellar structures in the presence and absence of 
CaCl2. The micelles have a diameter estimated to be 
approximately 5 nm. 
 
The presence of micellar structures resulting from the self-
assembly of Daptomycin in aqueous solution is consistent with 
the observed absence of ordered secondary structure. We have 
previously shown for Toll-like receptor agonist like 
lipopeptides,[14] and other model lipopeptides,[15] that micellar 
structures are correlated to unordered peptide conformation. In 
contrast, -sheet conformation is observed for extended fibrillar 
or nanotape structures.[14, 16] 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. SAXS data at the concentrations of Daptomycin indicated (a) in 
CaCl2 solutions with 100 mM KCl, molar ratio Daptomycin: CaCl2 = 4 : 1). As a 
reference 1 wt% Daptomycin = 6.17 mM, (b) in 100 mM KCl with no added 
CaCl2. For clarity of presentation, only every 5th measured data point is shown. 
 
SAXS was used to obtain quantitative information on the internal 
structure of Daptomycin micelles. The data were modelled using 
a core-shell sphere model using the software SASfit.[17] The data 
along with the model form factor fits are shown in Fig.5 and the 
fit parameters are listed in Table 1. The outer micelle radius was 
found to be R= (27.2±0.1) Å independent of concentration in the 
range 0.5 – 2 wt% Daptomycin, and in the presence or absence 
of CaCl2. In the form factor fits, the only concentration-
dependent terms are those relating to the scattering contrast of 
the shell and core and the inner core radius. In particular, at 2 
wt%, the inner core radius is larger and the relative scattering 
contrast of the inner core is more negative, indicating increased 
packing of hydrophobic units (which have a negative scattering 
density relative to the solvent) in the micelle core. Using the 
micelle radius R= (27.2±0.1) Å obtained from fitting SAXS data 
(SI Table S1), along with a molecular volume 1435 Å3 
(calculated at www.molinspiration.com), we estimate an 
association number of 59±6 for Daptomycin (concentration 
range 0.5 – 2 wt%) in 100 mM KCl solution with or without 0.25 
molar equivalents of CaCl2. In a previous study, the aggregation 
number was estimated from static light scattering data and found 
to be (18±2).[5a] 
 
In summary, in contrast to previous literature[7] we find clear 
evidence that Daptomycin can self-assemble into well-defined 
spherical micelles in the absence or presence of CaCl2 (at least 
up to 1:1 molar ratio of added CaCl2, i.e. covering the range 
previously studied). The structure of the micelles appears to be 
the same, with or without the added salt. It is remarkable that a 
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molecule such as Daptomycin with a large cyclic “headgroup” 
can self-assemble into spherical micelles with a relatively large 
association number. It seems likely that the conformation of the 
molecule (Scheme 1) will be such as to favour sequestration of 
the lipid chain and aromatic residues in the micelle core, with the 
polar residues forming the micelle corona. As indicated by the 
cac assay, micellization occurs at the same concentration with 
or without added CaCl2.  
Experimental Section 
Materials 
Daptomycin was obtained from Merck Millipore (USA) with a molecular 
weight of 1620.7 g mol-1 and a purity of 100% determined by HPLC. 
Potassium chloride was from Fisher Scientific (UK) and calcium chloride 
from Sigma-Aldrich (USA). 
Following previous reports,[3, 7, 9] Daptomycin was dissolved in 100 mM 
KCl solutions in the presence and absence of CaCl2, adding 0.25 molar 
or 1.00 equivalents of CaCl2. For reference, a sample containing 0.5 wt% 
Daptomycin with 100 mM KCl and 0.77 mM CaCl2 had pH 4.1, while a 
sample diluted to 0.05 wt% had pH 4.68.  
Cryo-TEM 
Experiments were carried out using a field emission cryo-electron 
microscope (JEOL JEM-3200FSC) operating at 200 kV. Images were 
taken using bright-field mode and zero loss energy filtering (omega type) 
with a slit with 20 eV. Micrographs were recorded using a Gatan 
Ultrascan 4000 CCD camera. The specimen temperature was 
maintained at -187 °C during the imaging. Vitrified specimens were 
prepared using an automated FEI Vitrobot device using Quantifoil 3.5/1 
holey carbon copper grids with 3.5 μm hole sizes. Grids were cleaned 
using a Gatan Solarus 9500 plasma cleaner just prior to use and then 
transferred into an environmental chamber of FEI Vitrobot at room 
temperature and 100% humidity. Thereafter, 3 μl of sample solution at 
0.5 wt% concentration was applied on the grid, blotted once for 1 second 
and then vitrified in a 1/1 mixture of liquid ethane and propane at -180 °C. 
Grids with vitrified sample solutions were maintained in a liquid nitrogen 
atmosphere and then cryo-transferred into the microscope. 
Pyrene fluorescence  
Fluorescence spectra were recorded with a Varian Cary Eclipse 
Fluorescence Spectrometer with samples in 4 mm inner Quartz cuvettes. 
The assays were performed using 1.3x10-3 – 0.13 wt.% Daptomycin, in 
2.3 x 10-5 wt.% pyrene solution. The samples were excited at λex = 380 
nm, and the fluorescence emission was measured for λ= (400-550nm).  
Circular Dichroism Spectroscopy 
CD spectra were recorded using a Chirascan spectropolarimeter (Applied 
Photophysics, UK). Each sample (0.1 wt% Daptomycin in 100 mM KCl 
and 0.154 mM or 0.617 mM CaCl2) was placed in a cover slip cuvette 
(0.1 mm thick). Spectra are presented with absorbance A < 2 at any 
measured point with a 0.5 nm step, 1 nm bandwidth, and 1 second 
collection time per step at 20 C. The Daptomycin solution was 
acclimatised at each temperature point for 10 minutes before 
measurements were taken. The CD signal from the background was 
subtracted from the CD data of the daptomycin solution. 
 
 
SAXS 
Experiments were performed on beamline B21 at Diamond Light Source, 
Harwell, UK. Solutions of Datptomycin (0.5, 1 and 2 wt% with 100 mM 
KCl and with or without CaCl2) were loaded into the 96 well plate of an 
EMBL BioSAXS robot. Aliquots of solutions (25 L) were then injected 
via an automated sample exchanger at a slow and very reproducible flux 
into a quartz capillary (1.8 mm internal diameter) in the X-ray beam. The 
quartz capillary was enclosed in a vacuum chamber, in order to 
avoid parasitic scattering. After the sample was injected in the capillary 
and reached the X-ray beam, the flow was stopped during the SAXS data 
acquisition. SAXS frames were collected with duration 20 s or 100 s). 
B21 operated with a fixed camera length (4.01 m) and fixed energy (12.4 
keV).  The images were captured using a Pilatus 2M detector. Data 
processing (background subtraction, radial averaging) was performed 
using the dedicated beamline software Scatter. 
SAXS data were modelled using the software SASfit[17] with model 
“Spherical Shell i”. A flat background was added in the case of the data 
from Diamond beamline B21, it was necessary to allow for a linear 
sloping background to fit the data from Maxlab beamline I911. The fit 
parameters are provided in Table S1. 
FTIR Spectroscopy 
Spectra were recorded using a Thermo Scientific Nicolet IS5 and a 
Nexus-FTIR spectrometer, both equipped with a DTGS detector. A 40 µl 
drop of the sample (6.17 mM Daptomycin in 100 mM KCl with or without 
1.54 mM or 6.17 mM CaCl2 in D2O) was sandwiched between two CaF2 
plate windows, with a 0.006 mm thick Mylar spacer) in a Specac 
GS20500 sample cell holder. Cells were heated using a Specac 4000 
series high stability heating controller, and a Specac electrical heating 
jacket. The sample was equilibrated at each temperature point for 10 
minutes before measurements were taken. Spectra were scanned 128 
times over the range of 900-4000 cm-1.  
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